Express News | KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
Earnings Call: KORU Medical Systems Sees Robust Growth in Q1 2024
Q1 2024 KORU Medical Systems Inc Earnings Call
Earnings Call Summary | KORU Medical Systems(KRMD.US) Q1 2024 Earnings Conference
The following is a summary of the KORU Medical Systems, Inc. (KRMD) Q1 2024 Earnings Call Transcript:Financial Performance:KORU Medical Systems, Inc. reported Q1 2024 revenue of $8.2 million, exhibiti
Express News | KORU Medical Systems : Craig-Hallum Cuts Target Price to $4 From $5
KORU Medical Systems, Inc. (KRMD) Q1 2024 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Q1 2024 Earnings Call Transcript
Express News | KORU Medical Systems Sees FY24 Revenue $31.2M-$33.2M Vs $38.6M Estimate
KORU Medical Systems Q1 2024 Adj EPS $(0.02) Beats $(0.04) Estimate, Sales $8.198M Beat $7.467M Estimate
KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 50 percent increase over losses of $(0.0
Express News | KORU Medical Systems Inc - Qtrly Shr Loss $0.04
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, Vs. Street Est of $7.5M
04:10 PM EDT, 05/01/2024 (MT Newswires) -- Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, vs. Street Est of $7.5M
Express News | KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
Express News | KORU Medical Systems Outlook FY Revenue USD 31.2-32.2 Million
KORU Medical Systems 1Q Loss/Shr 4c >KRMD
KORU Medical Systems 1Q Loss/Shr 4c >KRMD
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
KORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume
Express News | KORU Medical Systems Inc - Will Proceed Through Routine Bsi Assessment Process Without Suspension or Interruption of Company's Sale of Products in EU
Express News | KORU Medical Systems- Appeal of Assessment Report From Bsi on Recommendation Against Continued Certification on Prior Audit Nonconformance Was Upheld
Express News | KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
The Top Stocks With Selling Pressure Across the Russell Universe - Jefferies
Express News | KORU Medical Plans To Present Data Showing 97% Adherence On Its Freedom Infusion System For Large Volume Subcutaneous Administration At NHIA 2024 Conference
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercializ
No Data